Option Care Health (NASDAQ:OPCH) Trading Up 4.5% – Still a Buy?

Option Care Health, Inc. (NASDAQ:OPCH) was up 4.5% during trading on Wednesday . The company traded as high as $24.88 and last traded at $24.58. 2,180,041 shares traded hands during mid-day trading, a decline of 11% from the average session volume of 2,449,761 shares. The stock had previously closed at $23.52.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. UBS Group reiterated a “buy” rating on shares of Option Care Health in a report on Tuesday, June 16th. Weiss Ratings raised Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, September 11th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $24.00 target price (down from $26.00) on shares of Option Care Health in a report on Thursday, July 30th. Finally, The Goldman Sachs Group assumed coverage on shares of Option Care Health in a report on Monday, June 8th. They set a “neutral” rating and a $22.00 price objective for the company. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.92.

Option Care Health Stock Up 0.1%

The business’s 50 day moving average price is $23.24 and its 200-day moving average price is $24.12. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. The company has a market cap of $3.67 billion, a P/E ratio of 18.42, a PEG ratio of 1.42 and a beta of 0.61.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. Option Care Health’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, analysts anticipate that Option Care Health, Inc. will post 1.69 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. Raiffeisen Bank International AG boosted its stake in Option Care Health by 92.3% in the 2nd quarter. Raiffeisen Bank International AG now owns 250,000 shares of the company’s stock worth $5,330,000 after purchasing an additional 120,000 shares during the period. Norges Bank acquired a new stake in shares of Option Care Health in the 4th quarter valued at about $61,787,000. Sumitomo Mitsui Trust Group Inc. acquired a new stake in shares of Option Care Health in the 1st quarter valued at about $70,287,000. Squarepoint Ops LLC lifted its holdings in shares of Option Care Health by 234.1% in the second quarter. Squarepoint Ops LLC now owns 434,408 shares of the company’s stock valued at $9,110,000 after purchasing an additional 304,376 shares in the last quarter. Finally, Van Berkom & Associates Inc. bought a new stake in shares of Option Care Health in the first quarter valued at about $42,739,000. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion centers and other outpatient locations.

Its services include pharmacy and nursing support for intravenous and subcutaneous therapies, care coordination, patient education, clinical monitoring and reimbursement assistance.